Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Theanine for Relaxation and Mood in Cancer Patients in Surveillance
NCT07220447Phase 1Recruiting
- Sponsor
- City of Hope
- Start
- Apr 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in anxiety disorder (2 arms), sponsored by City of Hope. Primary endpoints: Adherence rates at 8 weeks and Visual Analog Scale-Relaxation at 42 days. Started Apr 2026; status: recruiting.
02
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT07220447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07220447.